Abstract
Diabetes and hypertension are two of the most prevalent chronic diseases afflicting mankind. Individuals with one of these maladies often suffer from the other and it is now increasingly recognized that such concurrence is greater than what would be predicted by chance alone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weidmann P, Ferrari P (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care 14: 220ā232
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinnelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N EngI Med 317: 350ā357
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595ā1607
Shen DC, Shieh SM, Fuh MMT, Wu D-A, Chen Y-DI, Reaven GM (1988) Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580ā583
Tarn AC, Drury PL (1986) Blood pressure in children, adolescent and young adults with type 1 (insulin-dependent) diabetes. Diabetologia 29: 275ā281
Mathieson ER, Ronn B, Jensen T, Storm B, Dechkert T (1990) Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 39: 245ā249
Norgaar K, Feldt-Rasmussen B, Borch-Jensen K, Saelan H, Deckert T (1990) Prevalence of hypertension in insulin-dependent diabetes mellitus. Diabetologia 33: 407ā410
Viberti GC (1991) Diabetic nephropathy: links with hypertension and atherosclerosis. Cardiovasc Risk Fact 1: 368ā374
Epstein M, Sowers JR (1992) Diabetes mellitus and hypertension. Hypertension 19: 403ā418
Feldt-Rasmussen B, Mathiesen ER, Decken T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type-1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 610ā617
Guyton AC (1991) Blood pressure control -special role of the kidneys and body fluids. Science 252: 1813ā1816
Sanchez-Martos J, Gutsowska J, Lopez-Novoa JM, Luque-Otero M, Fernandez M, Diaz Y, Ibarra J, Fernandez-Cruz A (1993) Volume expansion, natriuresis and atrial natriuretic peptide in type I and type II diabetes. Cardiovasc Risk Fact 3: 174ā180
Yuan C, Manunta P, Chen S, Hamlyn J, Pamnani M (1992) Hypertension induced by chronic ouabain administration in rats. FASEB J 6: A945
Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM (1992) Chronic reversible hypertension in rats induced by ouabain but not digoxin. Hypertension 20: 404 (abstract)
Manunta P, Evans G, Hamilton BP, Gann D, Resau J, Hamlyn JM (1992) A new syndrome with elevated plasma ouabain and hypertension secondary to an adrenocortical tumor. J Hypertens to [Suppl 4]: 527 (abstract)
Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 4: 20ā34
Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannin E (1986) Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 62: 1302ā1304
Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809ā817
Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885ā888
Hall JE, Coleman TG, Mezelle HL, Smith MJ (1990) Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol 258: F722 - F731
Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246ā2252
Sowers JR, Khoury S, Standley P, Zemel P (1991) Mechanism of hypertension in diabetes. Am J Hypertens 4: 177ā182
Sowers Jr, Standley P, Jacoper S, Resnick M (1993) Diabetes mellitus and hypertension: the double whammy. Cardiovasc Risk Fact 3: 164ā169
Anderson E, Mark A (1993) Cardiovascular and sympathetic actions of insulin: the insulin hypothesis of hypertension revisited. Cardiovasc Risk Fact 3: 159ā163
Kramer HJ, Meyer-Lehnert H, Michel H, Predel H (1991) Endogenous natriuretic and ouabain-like factors: their roles in body fluid volume and blood pressure regulation. Am J Hypertens 4: 81ā89
Furchgott RF (1990) Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand 139: 257ā270
Kamata K, Miyata N, Kasuya Y (1989) Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97: 614ā618
Harris KH, MacLeod KM (1988) Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 153: 55ā64
Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S (1989) Endothelin binding to cultured calf adrenal zona glomerulose cells and stimulation of aldosterone secretion. J Clin Invest 84: 1032ā1035
Boarder MR, Marriott DB (1988) Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromattin cells. J Cardiovasc Pharmacol 13 [Suppl 5]: S233ā5224
Vierhapper H, Wagner O, Nowotny P, WaldhƤusl W (1990) Effect of endothelin 1 in man. Circulation 81: 1415ā1418
Ohno A, Naruse M, Kato S, Hosaka M, Naruse K, Demura H (1992) Endothelin-specific antibodies decrease blood pressure and increase glomerular filtration rate and renal plasma flow in spontaneously hypertensives rats. J Hypertens 10: 781ā785
Nishikibe M, Ikada M, Tsuchida S, Fukuroda T, Shimamoto K, Kobayashy M, Ishikawa K, Yano M, Ikemoto F (1992) Antihypertensive effect of a newly synthesized endothelin antagonist, BO-123, in genetic hypertension models. J Hypertens 10 [suppl 4]: P53
Clozel M, Breu V, Burri K, Cassai JM, Fischli W, Gray GA, Hirth G, Loeffler BM, Mueller M, Neidhart W, Ramuz H (1993) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365: 759ā761
Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T (1990) Plasma immunoreactive endothelin in essential hypertension. Am J Med 88: 654
Lƶscher TF, Seo BG, Bhuler FR (1993) Controversy on endothelin in hypertension. Hypertension 21: 752ā757
Myauchi T, Yanagisawa M, Suzuki N, Iida K, Sugishita Y, Fujino M, Saito T, Goto K, Masaki T (1989) Venous plasma concentrations of endothelin in normal and hypertensive subjects (abstract). Circulation 8o [Suppl II]: II - 2280
Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ (1990) A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 78: 261
Schrader J, Teebe U, Borries M, Ruschitzka F, Schoel G, Kandt M, Warneke G, Zurchner C, Weber MH, Neu U, Rath W, Henning HV (1990) Plasma Endothelin bei normalen Personen and Patienten mit nephrologisch-rheumatologischen and kardiovaskularen Erkrankungen. Klin Wochenschr 68: 774
Schiffrin EL, Thibahult G (1991) Plasma endothelin in human essential hypertension. Am J Hyper-tens 4: 303
Shihiri M, Mirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inque A, Marumo F (1990) Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 55: 493
Saito Y, Nakao K, Mukoyama M, Shirakami G, Ito H, Yamada T, Arai H, Hosoda K, Suga S, Jougasaki M, Ogawa Y, Nakajima S, Veda M, Imura H (1990) Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 55: 734
Noth RH, Lassman N, Tan SY, Fernandez-Cruz A, Mulrow PJ (1977) Age and the renin-aldosterone system. Arch Intern Med 137: 1414ā1417
Fernandez-Cruz A, Martin P, Fernandez L, Sanchez J, Ibarra J, Moya J, Fernandez-Durango R, Gonzalez G, Martell N, Fernandez-Pinilla C, Luque Otero M (1993) Plasma endothelin is increased in young essential hypertensives but not in elderly essential nor in diabetic hypertensives. J Hypertension 11 [Suppl 5]: 8146ā8147
Takahashi K, Ghatei M. A, Lam H.C, OāHalloran DJ, Bloom SR (1990) Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306ā310
Kawamura M, Ohgawara H, Naruse M, Suziki N, Iwasaki N (1992) Increase plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 15: 1396ā1399
Collier A, Leach JP, Mclellan A, Jardine A, Morton JJ, Small M (1992) Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 8: 1038ā1040
Lee YJ, Shin SJ, Tsai JH (1994) Increased urinary endothelin-s-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 4: 263ā266
Lerman A, Edwards BS, Hallett JW, Heublein DM, Sondberg SM, Burnett JC Jr (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 321: 997ā1001
Patifo F, Ibarra J, Molino A, Fernandez-Durango R, Moya J, Fernandez-Cruz A (1994) Increased plasma endothelin in diabetes: an atherosclerosis marker? Diabetologia 37: 334
Haak T, Jungmann E, Felber A, Hillmann U, Henning K (1992) Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5: 161ā166
de Juan JA, Moya J, Garcia de la Cova M, Fernandez-Durango R, Fernandez-Cruz A (1993) Identification and characterization of endothelin receptor subtype ( ETb) in rat retina. J Neurochem 61: 1113ā1119
Stewart DJ, Kubac G, Costello KB, Cernacek P (1991) Increased plasma endothelin 1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18: 38
Estrada V, Tellez MJ, Moya J, Fernandez-Durango R, Egido J, Fernandez-Cruz A (1994) High plasma levels of endothelin 1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 7: 1085ā1089
Omland T, Lie RT, Aakvaag A, Arsland T, Dickstein K (1994) Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573ā1579
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fernandez-Cruz, A. et al. (1995). Endothelin in Hypertension and Diabetes Mellitus. In: LĆ¼scher, T.F. (eds) The Endothelium in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79803-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-79803-0_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79805-4
Online ISBN: 978-3-642-79803-0
eBook Packages: Springer Book Archive